Product Code: BT 2486
"Cell-based assays market projected to grow at a CAGR of 8.4% during the forecast period"
The global cell-based assays market is expected to reach USD 19.92 billion by 2022, at a CAGR of 8.4% from 2017 to 2022. The major factors driving this market are the growing funding and investments in R&D, the increasing prevalence of chronic disorders, rising drug discovery activity, and the advantages of cell-based assays over alternative technologies. On the other hand, the growth of this market is hindered to some extent due to the high cost of instruments and stringent regulatory policies
"Consumables to register the highest CAGR during the forecast period"
The cell-based assays market is classified on the basis of products into consumables, instruments, services and software. The consumables segment is further segmented into reagents, assay kits, microplates, cell lines, probes & labels and other consumables. The consumables segment is expected to grow at the highest rate during the forecast period. This is attributed to the effective and innovative products developed and launched by various players in the market. Such products are encouraging acceptance from consumers.
"Pharmaceutical and biotechnology companies to dominate the cell-based assays market during the forecast period"
The cell-based assays market is segmented by end users into pharmaceutical and biotechnology companies, academic and government institutions, contract research organizations, and other end users such as hospitals, clinical laboratories, and environmental monitoring laboratories. In 2017, pharmaceutical and biotechnology companies segment is expected to command the largest share and is also estimated to grow at the fastest rate as compared to the other segments. This positive growth can be attributed to the increasing adoption of cell-based assays for drug discovery by these end users, particularly in developed countries across North America and Europe.
"APAC is estimated to be the fastest growing regional segment in the global cell-based assays market during the forecast period"
Geographically, the cell-based assays market is dominated by North America, followed by Europe. The Asia-Pacific region is estimated to grow at the fastest rate which can be attributed to the increased investments in the healthcare sector, rising expenditure on healthcare along with increased coverage of health insurance, and a rise in disposable incomes especially in countries like China, Japan, and India.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type - Tier 1 - 25 %, Tier 2 - 35% and Tier 3 - 40%
- By Designation - C level - 35%, Director level - 25%, Others - 40%
- By Region - North America - 43%, Europe - 19%, APAC - 29%, RoW - 9%
The key players in the market are Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), GE Healthcare (U.K), Thermo Fisher Scientific Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), BioTek Instruments, Inc. (U.S.), Lonza Group (U.S.), ProQinase GmbH (Germany), Charles River Laboratories, Inc (U.S.), Cisbio Bioassays (France), Miltenyi Biotec (Germany), Cell Biolabs, Inc. (U.S.), DiscoverX Corporation (U.S.), Marin Biologic Laboratories (U.S.), Biospherix, Ltd (U.S.), Essen BioScience Inc. (U.S.), Life Technologies Corporation (U.S.), BioAgilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Aurelia Bioscience Ltd. (U.K. ), Selexis SA (U.S.), and QGel SA (Switzerland).
Research Coverage:
The report analyses the cell-based assays market by products, applications, end users, and regions. Apart from a comprehensive geographic & product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise of product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The market research data, current market size, and forecast of the future trends in the market will help established players as well as new entrants make necessary decisions regarding product offerings, geographic focus, change in strategic approach, and levels of output to remain successful in the cell-based assays market.
Key Benefits of Buying the Report:
This report will enable both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the below-mentioned strategies to strengthen their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the cell-based assays market
- Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the cell-based assays market
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the cell-based assays market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various cell-based assays across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell-based assays market
TABLE OF CONTENTS
1. INTRODUCTION
- 1.1. OBJECTIVES OF THE STUDY
- 1.2. MARKET DEFINITION
- 1.2.1. MARKETS COVERED
- 1.2.2. YEARS CONSIDERED FOR THE STUDY
- 1.3. CURRENCY
- 1.4. LIMITATIONS
- 1.5. STAKEHOLDERS
2. RESEARCH METHODOLOGY
- 2.1. SECONDARY DATA
- 2.1.1. KEY DATA FROM SECONDARY SOURCES
- 2.2. PRIMARY DATA
- 2.2.1. KEY DATA FROM PRIMARY SOURCES
- 2.3. MARKET SIZE ESTIMATION
- 2.3.1. BOTTOM-UP APPROACH
- 2.3.2. TOP-DOWN APPROACH
- 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
- 2.5. ASSUMPTIONS FOR THE STUDY
3. EXECUTIVE SUMMARY
4. PREMIUM INSIGHTS
- 4.1. CELL-BASED ASSAYS: MARKET OVERVIEW
- 4.2. GEOGRAPHIC ANALYSIS: CELL-BASED ASSAYS MARKET, BY END USER (2017)
- 4.3. GEOGRAPHICAL SNAPSHOT OF THE CELL-BASED ASSAYS MARKET
- 4.4. CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017 VS. 2022
5. MARKET OVERVIEW
- 5.1. INTRODUCTION
- 5.2. MARKET DYNAMICS
- 5.2.1. DRIVERS
- 5.2.1.1. Rising incidence of chronic diseases
- 5.2.1.2. Growing availability of funds for research
- 5.2.1.3. Growing preference for cell-based assays
- 5.2.1.4. Increasing drug discovery activity
- 5.2.2. RESTRAINT
- 5.2.2.1. High cost of instruments, restrictions on reagent use
- 5.2.3. OPPORTUNITY
- 5.2.3.1. Asian countries to offer opportunities in the cell-based assay market
6. CELL-BASED ASSAYS MARKET, BY PRODUCT AND SERVICE
- 6.1. INTRODUCTION
- 6.2. CONSUMABLES
- 6.2.1. REAGENTS
- 6.2.2. ASSAY KITS
- 6.2.2.1. Reporter gene assays
- 6.2.2.2. Cell growth assays
- 6.2.2.3. Second messenger assays
- 6.2.2.4. Cell death assays
- 6.2.2.5. Other assays
- 6.2.3. MICROPLATES
- 6.2.4. CELL LINES
- 6.2.4.1. Immortalized cell lines
- 6.2.4.2. Primary cell lines
- 6.2.4.3. Stem cell lines
- 6.2.5. PROBES AND LABELS
- 6.2.6. OTHER CONSUMABLES
- 6.3. INSTRUMENTS
- 6.4. SERVICES
- 6.5. SOFTWARE
7. CELL-BASED ASSAYS MARKET, BY APPLICATION
- 7.1. INTRODUCTION
- 7.2. DRUG DISCOVERY
- 7.3. BASIC RESEARCH
- 7.4. ADME STUDIES
- 7.5. PREDICTIVE TOXICOLOGY
- 7.6. OTHER APPLICATIONS
8. CELL-BASED ASSAYS MARKET, BY END USER
- 8.1. INTRODUCTION
- 8.2. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
- 8.3. ACADEMIC & GOVERNMENT INSTITUTIONS
- 8.4. CONTRACT RESEARCH ORGANIZATIONS
- 8.5. OTHER END USERS
9. CELL-BASED ASSAYS MARKET, BY REGION
- 9.1. INTRODUCTION
- 9.2. NORTH AMERICA
- 9.2.1. U.S.
- 9.2.2. CANADA
- 9.3. EUROPE
- 9.3.1. GERMANY
- 9.3.2. FRANCE
- 9.3.3. U.K.
- 9.3.4. ITALY
- 9.3.5. SPAIN
- 9.3.6. ROE
- 9.4. ASIA
- 9.4.1. CHINA
- 9.4.2. JAPAN
- 9.4.3. INDIA
- 9.4.4. REST OF ASIA
- 9.5. REST OF THE WORLD
10. COMPETITIVE LANDSCAPE
- 10.1. INTRODUCTION
- 10.2. MARKET SHARE ANALYSIS
- 10.3. VENDOR DIVE OVERVIEW
- 10.3.1. VISIONARY LEADERS
- 10.3.2. INNOVATORS
- 10.3.3. DYNAMIC DIFFERENTIATORS
- 10.3.4. EMERGING COMPANIES
- 10.4. COMPETITIVE BENCHMARKING
- 10.4.1. ANALYSIS OF PRODUCT PORTFOLIO OF MAJOR PLAYERS IN THE CELL-BASED ASSAYS MARKET (25 PLAYERS)
- 10.4.2. BUSINESS STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE CELL-BASED ASSAYS MARKET (25 PLAYERS)
Top 25 companies analysed for this study are - Becton, Dickinson and Company. (U.S.), Cell Signaling Technology (U.S.), Danahar Corporation (U.S.), Cisbio Bioassays (France), Merck KGaA (Germany), GE Healthcare (U.K), DiscoverX Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S.), PerkinElmer Inc. (U.S.), Promega Corporation (U.S.), ProQinase GmbH (Germany), Charles River Laboratories International, Inc. (U.S.), Marine Biological Laboratory (U.S.), Biospherix, Ltd. (U.S.), Essen BioScience (U.S.), Miltenyi Biotec (Switzerland), BioAgilytix Labs. (U.S.), Enzo Life Sciences, Inc. (Switzerland), Lonza (Switzerland), Aurelia Bioscience Ltd. (U.K), Selexis SA (U.S.), Life Technologies Corporation (U.S.), Cell Biolabs, Inc. (U.S.), BioTek Instruments, Inc. (U.S.), QGel SA (Switzerland)
11. COMPANY PROFILES (Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy)*
- 11.1. THERMO FISHER SCIENTIFIC INC.
- 11.2. BECTON, DICKINSON AND COMPANY
- 11.3. GENERAL ELECTRIC COMPANY
- 11.4. DANAHER CORPORATION
- 11.5. MERCK KGAA
- 11.6. LONZA GROUP LTD.
- 11.7. PERKINELMER, INC.
- 11.8. CHARLES RIVER LABORATORIES, INC.
- 11.9. CELL SIGNALING TECHNOLOGY, INC.
- 11.10. PROMEGA CORPORATION
- 11.11. CISBIO BIOASSAYS
- 11.12. CELL BIOLABS, INC.
- 11.13. DISCOVERX CORPORATION
*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development's, Business Strategy might not be captured in case of unlisted companies.
12. APPENDIX
- 12.1. INSIGHTS FROM INDUSTRY EXPERTS
- 12.2. DISCUSSION GUIDE
- 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
- 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
- 12.5. AVAILABLE CUSTOMIZATIONS
- 12.6. RELATED REPORTS
- 12.7. AUTHOR DETAILS
LIST OF TABLES
- TABLE 1: INCREASE IN CANCER PATIENT POPULATION, BY CANCER TYPE
- TABLE 2: CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 3: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY TYPE, 2015-2022 (USD MILLION)
- TABLE 4: CELL-BASED ASSAYS MARKET FOR CONSUMABLES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 5: CELL-BASED ASSAYS MARKET FOR REAGENTS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 6: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY TYPE, 2015-2022 (USD MILLION)
- TABLE 7: CELL-BASED ASSAYS MARKET FOR ASSAY KITS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 8: CELL-BASED ASSAYS MARKET FOR REPORTER GENE ASSAYS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 9: CELL-BASED ASSAYS MARKET FOR CELL GROWTH ASSAYS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 10: CELL-BASED ASSAYS MARKET FOR SECOND MESSENGER ASSAYS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 11: CELL-BASED ASSAYS MARKET FOR CELL DEATH ASSAYS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 12: OTHER CELL-BASED ASSAYS MARKET, BY REGION, 2015-2022 (USD MILLION)
- TABLE 13: CELL-BASED ASSAYS MARKET FOR MICROPLATES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 14: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 15: CELL-BASED ASSAYS MARKET FOR CELL LINES, BY TYPE, 2015-2022 (USD MILLION)
- TABLE 16: CELL-BASED ASSAYS MARKET FOR IMMORTALIZED CELL LINES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 17: CELL-BASED ASSAYS MARKET FOR PRIMARY CELL LINES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 18: CELL-BASED ASSAYS MARKET FOR STEM CELL LINES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 19: CELL-BASED ASSAYS MARKET FOR PROBES AND LABELS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 20: CELL-BASED ASSAYS MARKET FOR OTHER CONSUMABLES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 21: CELL-BASED ASSAYS MARKET FOR INSTRUMENTS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 22: CELL-BASED ASSAYS MARKET FOR SERVICES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 23: CELL-BASED ASSAYS MARKET FOR SOFTWARE, BY REGION, 2015-2022 (USD MILLION) 58
- TABLE 24: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 25: CELL-BASED ASSAYS MARKET FOR DRUG DISCOVERY, BY REGION, 2015-2022 (USD MILLION)
- TABLE 26: CELL-BASED ASSAYS MARKET FOR BASIC RESEARCH, BY REGION, 2015-2022 (USD MILLION)
- TABLE 27: CELL-BASED ASSAYS MARKET FOR ADME STUDIES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 28: CELL-BASED ASSAYS MARKET FOR PREDICTIVE TOXICOLOGY, BY REGION, 2015-2022 (USD MILLION)
- TABLE 29: OTHER CELL-BASED ASSAY APPLICATIONS MARKET, BY REGION, 2015-2022 (USD MILLION)
- TABLE 30: CELL-BASED ASSAYS MARKET SIZE, BY END USER, 2015-2022 (USD MILLION)
- TABLE 31: CELL-BASED ASSAYS MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
- TABLE 32: CELL-BASED ASSAYS MARKET SIZE FOR ACADEMIC & GOVERNMENT INSTITUTIONS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 33: CELL-BASED ASSAYS MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 34: CELL-BASED ASSAYS MARKET SIZE FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
- TABLE 35: CELL-BASED ASSAYS MARKET, BY REGION, 2015-2022 (USD MILLION)
- TABLE 36: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
- TABLE 37: NORTH AMERICA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 38: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 39: NORTH AMERICA: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 40: U.S.: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 41: U.S.: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 42: U.S.: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 43: CANADA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 44: CANADA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 45: CANADA: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 46: EUROPE: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
- TABLE 47: EUROPE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 48: EUROPE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 49: EUROPE: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION) 87
- TABLE 50: GERMANY: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 51: GERMANY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 52: GERMANY: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 53: FRANCE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 54: FRANCE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 55: FRANCE: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 56: U.K.: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 57: U.K.: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 58: U.K.: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 59: ITALY: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 60: ITALY: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 61: ITALY: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 62: SPAIN: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 63: SPAIN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 64: SPAIN: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 65: ROE: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 66: ROE: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 67: ROE: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 68: ASIA: CELL-BASED ASSAYS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
- TABLE 69: ASIA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 70: ASIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 71: ASIA: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 72: CHINA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 73: CHINA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 74: CHINA: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 75: JAPAN: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 76: JAPAN: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 77: JAPAN: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 78: INDIA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 79: INDIA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 80: INDIA: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 81: ROA: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 82: ROA: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 83: ROA: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
- TABLE 84: ROW: CELL-BASED ASSAYS MARKET SIZE, BY PRODUCT & SERVICE, 2015-2022 (USD MILLION)
- TABLE 85: ROW: CELL-BASED ASSAYS MARKET, BY APPLICATION, 2015-2022 (USD MILLION)
- TABLE 86: ROW: CELL-BASED ASSAYS MARKET, BY END USER, 2015-2022 (USD MILLION)
LIST OF FIGURES
- FIGURE 1: GLOBAL CELL-BASED ASSAYS MARKET
- FIGURE 2: RESEARCH DESIGN
- FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
- FIGURE 4: CELL-BASED ASSAYS MARKET: BOTTOM-UP APPROACH
- FIGURE 5: CELL-BASED ASSAYS MARKET: TOP-DOWN APPROACH
- FIGURE 6: DATA TRIANGULATION METHODOLOGY
- FIGURE 7: GLOBAL CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, 2017 VS. 2022 (USD BILLION)
- FIGURE 8: GLOBAL CELL-BASED ASSAYS MARKET, BY APPLICATION, 2017 VS. 2022 (USD BILLION)
- FIGURE 9: GLOBAL CELL-BASED ASSAYS MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
- FIGURE 10: GEOGRAPHIC SNAPSHOT OF THE GLOBAL CELL-BASED ASSAYS MARKET
- FIGURE 11: GLOBAL CELL-BASED ASSAYS MARKET TO WITNESS MODERATE GROWTH DURING THE FORECAST PERIOD
- FIGURE 12: PHARMACEUTICAL AND BIOTECHNOLOGICAL COMPANIES ARE EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CELL-BASED ASSAYS MARKET IN 2017
- FIGURE 13: ASIA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
- FIGURE 14: DRUG DISCOVERY SEGMENT WILL CONTINUE TO DOMINATE THE CELL-BASED ASSAYS MARKET IN 2022
- FIGURE 15: CELL-BASED ASSAYS MARKET: DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 16: CONSUMABLES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING 2017-2022
- FIGURE 17: DRUG DISCOVERY WILL CONTINUE TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD
- FIGURE 18: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DOMINATE THE CELL-BASED ASSAYS MARKET DURING THE FORECAST PERIOD
- FIGURE 19: ASIAN CELL-BASED ASSAYS MARKET TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
- FIGURE 20: ASIAN CELL-BASED ASSAYS MARKET TO REGISTER THE HIGHER CAGR DURING FORECAST PERIOD
- FIGURE 21: NORTH AMERICA: CELL-BASED ASSAYS MARKET SNAPSHOT
- FIGURE 22: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST SHARE OF THE END-USER MARKET IN NORTH AMERICA
- FIGURE 23: CONSUMABLES, THE LARGEST SEGMENT IN THE U.S. CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, IN 2017
- FIGURE 24: DRUG DISCOVERY APPLICATION SEGMENT TO DOMINATE THE CANADIAN MARKET IN 2017
- FIGURE 25: CONTRACT RESEARCH ORGANIZATIONS, THE FASTEST-GROWING END-USER SEGMENT IN EUROPE
- FIGURE 26: CONSUMABLES ESTIMATED TO BE THE LARGEST PRODUCT & SERVICE SEGMENT IN THE GERMAN CELL-BASED ASSAYS MARKET IN 2017
- FIGURE 27: CONSUMABLES TO DOMINATE THE FRENCH CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, IN 2017
- FIGURE 28: CONSUMABLES, THE LARGEST PRODUCT & SERVICE SEGMENT IN THE U.K. MARKET IN 2017
- FIGURE 29: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO BE THE LARGEST END-USER SEGMENT IN THE ITALIAN MARKET, 2017
- FIGURE 30: CONSUMABLES, THE LARGEST PRODUCT SEGMENT IN THE SPANISH MARKET IN 2017
- FIGURE 31: ROE MARKET, BY END USER: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ESTIMATED TO HOLD LARGEST SHARE IN 2017
- FIGURE 32: ASIA: CELL-BASED ASSAYS MARKET SNAPSHOT
- FIGURE 33: CONSUMABLES TO ACCOUNT FOR THE LARGEST PRODUCT SEGMENT OF THE CELL-BASED ASSAYS MARKET IN ASIA IN 2017
- FIGURE 34: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST END-USER SEGMENT OF THE MARKET IN CHINA IN 2017
- FIGURE 35: CONSUMABLES TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET, BY PRODUCT & SERVICE, IN JAPAN, 2017
- FIGURE 36: DRUG DISCOVERY TO ACCOUNT FOR THE LARGEST APPLICATION OF THE CELL-BASED ASSAYS MARKET IN INDIA IN 2017
- FIGURE 37: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO ACCOUNT FOR THE LARGEST END-USER OF THE CELL-BASED ASSAYS MARKET IN ROA IN 2017
- FIGURE 38: CONSUMABLES TO ACCOUNT FOR THE LARGEST SHARE OF THE CELL-BASED ASSAYS MARKET IN ROW IN 2017
- FIGURE 39: GLOBAL CELL-BASED ASSAYS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
- FIGURE 40: DIVE CHART
- FIGURE 41: THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
- FIGURE 42: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2016)
- FIGURE 43: GENERAL ELECTRIC COMPANY: COMPANY SNAPSHOT (2016)
- FIGURE 44: DANAHER CORPORATION: COMPANY SNAPSHOT (2016)
- FIGURE 45: MERCK KGAA: COMPANY SNAPSHOT (2016)
- FIGURE 46: LONZA GROUP LTD.: COMPANY SNAPSHOT (2016)
- FIGURE 47: PERKINELMER, INC.: COMPANY SNAPSHOT (2017)
- FIGURE 48: CHARLES RIVER LABORATORIES, INC.: COMPANY SNAPSHOT (2016)
